Anti-apoptotic actions of PPAR-gamma against ischemic stroke (Q37686356)

22 August 2017

1 reference

title

Anti-apoptotic actions of PPAR-gamma against ischemic stroke (English)

1 reference

22 August 2017

0 references

Wen-Hsuan Fong

1

1 reference

22 August 2017

Hsin-Da Tsai

2

1 reference

22 August 2017

Yu-Chang Chen

3

1 reference

22 August 2017

Jui-Sheng Wu

4

1 reference

22 August 2017

Teng-Nan Lin

5

1 reference

22 August 2017

3 February 2010

1 reference

22 August 2017

Molecular Neurobiology

1 reference

22 August 2017

41

1 reference

22 August 2017

2-3

1 reference

22 August 2017

180-186

1 reference

https://scigraph.springernature.com/pub.10.1007/s12035-010-8103-y

22 August 2017

0 references

1 reference

https://api.crossref.org/works/10.1007%2FS12035-010-8103-Y

Identification and regulation of novel PPAR-gamma splice variants in human THP-1 macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-010-8103-Y

Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-010-8103-Y

Safety issues and prospects for future generations of PPAR modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-010-8103-Y

Hypertension and abnormal fat distribution but not insulin resistance in mice with P465L PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-010-8103-Y

Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-010-8103-Y

The fatty acid and aldehyde composition of the major phospholipids of mouse brain.

21 January 2018

1 reference

12 December 2020

Drug therapies for stroke and traumatic brain injury often display U-shaped dose responses: occurrence, mechanisms, and clinical implications

1 reference

12 December 2020

Rosiglitazone and PPAR-gamma overexpression protect mitochondrial membrane potential and prevent apoptosis by upregulating anti-apoptotic Bcl-2 family proteins

1 reference

12 December 2020

15d-Prostaglandin J2 activates peroxisome proliferator-activated receptor-gamma, promotes expression of catalase, and reduces inflammation, behavioral dysfunction, and neuronal loss after intracerebral hemorrhage in rats

1 reference

12 December 2020

Receptor-independent actions of PPAR thiazolidinedione agonists: is mitochondrial function the key?

1 reference

12 December 2020

Peroxisome proliferator-activated receptor gamma up-regulates the Bcl-2 anti-apoptotic protein in neurons and induces mitochondrial stabilization and protection against oxidative stress and apoptosis.

1 reference

12 December 2020

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

1 reference

12 December 2020

PPAR gamma is required for placental, cardiac, and adipose tissue development

1 reference

12 December 2020

Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligands: novel pharmacological agents in the treatment of ischemia reperfusion injury.

1 reference

12 December 2020

Cyclooxygenase-1 and bicistronic cyclooxygenase-1/prostacyclin synthase gene transfer protect against ischemic cerebral infarction.

1 reference

12 December 2020

Glitazones differentially regulate primary astrocyte and glioma cell survival. Involvement of reactive oxygen species and peroxisome proliferator-activated receptor-gamma.

1 reference

12 December 2020

A unified nomenclature system for the nuclear receptor superfamily

1 reference

12 December 2020

Neuronal PPARgamma deficiency increases susceptibility to brain damage after cerebral ischemia

1 reference

12 December 2020

A peroxisome proliferator-activated receptor-gamma agonist reduces infarct size in transient but not in permanent ischemia

1 reference

12 December 2020

Peroxisome proliferator-activated receptor-gamma ligands reduce inflammation and infarction size in transient focal ischemia

1 reference

12 December 2020

Anti-apoptotic effects of rosiglitazone in hypercholesterolemic rabbits subjected to myocardial ischemia and reperfusion

1 reference

12 December 2020

Free arachidonic acid and other lipids in the nervous system during early ischemia and after electroshock

1 reference

12 December 2020

Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L)

1 reference

12 December 2020

PPARs and the cardiovascular system

1 reference

12 December 2020

MRI monitoring of focal cerebral ischemia in peroxisome proliferator-activated receptor (PPAR)-deficient mice.

1 reference

12 December 2020

Genetic analysis of four novel peroxisome proliferator activated receptor-gamma splice variants in monkey macrophages

1 reference

12 December 2020

15d-prostaglandin J2 protects brain from ischemia-reperfusion injury

1 reference

12 December 2020

Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery

1 reference

12 December 2020

Peroxisome proliferator-activated receptor gamma and metabolic disease.

1 reference

12 December 2020

The PPARgamma ligand, rosiglitazone, reduces vascular oxidative stress and NADPH oxidase expression in diabetic mice.

1 reference

12 December 2020

PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation

1 reference

12 December 2020

15d-PGJ2: the anti-inflammatory prostaglandin?

1 reference

12 December 2020

Rescue of neurons from ischemic injury by peroxisome proliferator-activated receptor-gamma requires a novel essential cofactor LMO4

1 reference

12 December 2020

The biochemistry of apoptosis

1 reference

12 December 2020

Rosiglitazone acts as a neuroprotectant in retinal cells via up-regulation of sestrin-1 and SOD-2.

1 reference

12 December 2020

Protection of endothelial survival by peroxisome proliferator-activated receptor-delta mediated 14-3-3 upregulation

1 reference

12 December 2020

PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines

1 reference

12 December 2020

Thiazolidinedione activation of peroxisome proliferator-activated receptor gamma can enhance mitochondrial potential and promote cell survival.

1 reference

12 December 2020

Molecular targets in cerebral ischemia for developing novel therapeutics

1 reference

12 December 2020

Structure of the intact PPAR-gamma-RXR- nuclear receptor complex on DNA

1 reference

12 December 2020

Ligand-activated peroxisome proliferator-activated receptor-gamma protects against ischemic cerebral infarction and neuronal apoptosis by 14-3-3 epsilon upregulation

1 reference

12 December 2020

PPARgamma gene transfer sustains apoptosis, inhibits vascular smooth muscle cell proliferation, and reduces neointima formation after balloon injury in rats

1 reference

12 December 2020

Cellular and molecular effects of polyunsaturated fatty acids in brain ischemia and injury

1 reference

12 December 2020

Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors

1 reference

12 December 2020

Nitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor gamma ligand

1 reference

12 December 2020

PPAR-gamma: therapeutic target for ischemic stroke

1 reference

12 December 2020

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

1 reference

12 December 2020

U-shaped dose-responses in biology, toxicology, and public health

1 reference

12 December 2020

Activation of peroxisome proliferator-activated receptor-gamma by rosiglitazone protects human islet cells against human islet amyloid polypeptide toxicity by a phosphatidylinositol 3'-kinase-dependent pathway.

1 reference

12 December 2020

PPARgamma and its ligands: therapeutic implications in cardiovascular disease.

1 reference

12 December 2020

PPARs as new therapeutic targets for the treatment of cerebral ischemia/reperfusion injury

1 reference

12 December 2020

In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone

1 reference

12 December 2020

PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases

1 reference

12 December 2020

Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms

1 reference

12 December 2020

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

12 December 2020

Thiazolidenediones mediate apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 functions independently of PPARgamma

1 reference

12 December 2020

Aspects of the regulatory mechanisms of PPAR functions: analysis of a bidirectional response element and regulation by sumoylation

1 reference

12 December 2020

Arachidonic acid and its metabolites in cerebral ischemia

1 reference

12 December 2020

The mechanisms of action of PPARs

1 reference

12 December 2020

Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists

1 reference

12 December 2020

Identification of a functional peroxisome proliferator-activated receptor response element in the rat catalase promoter.

1 reference

12 December 2020

The BCL-2 protein family: opposing activities that mediate cell death

1 reference

12 December 2020

10.1007/S12035-010-8103-Y

Identifiers

DOI

1 reference

22 August 2017

1 reference